Results 201 to 210 of about 275,378 (374)

Adrenal insufficiency is seen in more than one-third of patients during ongoing low-dose prednisolone treatment for rheumatoid arthritis.

open access: yesEuropean Journal of Endocrinology, 2017
S. Borresen   +10 more
semanticscholar   +1 more source

Chinese Guidelines for Diagnosis and Treatment of Chronic Rhinosinusitis (2024)

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Chronic rhinosinusitis (CRS), a complex inflammatory disease with heterogeneous pathogenesis, demands evolving evidence‐based strategies. Since the 2018 Chinese guidelines and EPOS2020, international advances in CRS immunopathology and biologics have revolutionized therapeutic approaches, particularly through phenotype–endotype classification ...
Subspecialty Group of Rhinology   +4 more
wiley   +1 more source

Clinical features and recurrence patterns of pediatric idiopathic orbital inflammatory disease. [PDF]

open access: yesBMC Ophthalmol
Li Z   +7 more
europepmc   +1 more source

Immobilisation of lipase on the surface of magnetic nanoparticles and non‐porous glass beads for regioselective acetylation of prednisolone [PDF]

open access: bronze, 2013
Sabrieh Ghasemi   +5 more
openalex   +1 more source

Quantification of steroid hormones in free‐ranging Apennine wolf Canis lupus italicus hair samples collected post‐mortem

open access: yesWildlife Biology, EarlyView.
After decades of dramatic reductions in their populations, Italian wolves have begun recolonizing parts of their historic range. This growth in populations can lead to potential conflicts with human activities, which remain the main cause of wolf mortality.
Ilaria Troisio   +8 more
wiley   +1 more source

Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Nemolizumab, an anti‐interleukin‐31 receptor A monoclonal antibody, has been approved in Japan for treating atopic dermatitis (AD)‐associated pruritus. While it is effective for itch control, nemolizumab‐associated cutaneous adverse events have been increasingly recognized, yet their clinical features remain poorly characterized. In this study,
Wataru Sasaki   +24 more
wiley   +1 more source

Natural Killer Cell Activity and Response to Neoadjuvant Treatment in Breast Cancer Patients. [PDF]

open access: yesInt J Mol Sci
Gamborg-Kvist SH   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy